VTRS Viatris Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
18:18
Jul 26
Jul 26
Viatris cheap generic drug leader.
Viatris es un líder en fármacos genéricos que cotiza a solo 6x beneficios, en un sector defensivo y en crecimiento. El mercado sobreestima los riesgos y la compañía está extremadamente barata respecto a su media histórica, de forma similar a la oportunidad que ofreció Teva antes de doblar su valor.
HIGH
13:47
Mar 17
Mar 17
Viatris trades at ~5.5x forward P/E following a major restructuring, debt paydown, and a 170% jump in open job positions. The massive spike in hiring indicates growth rather than maintenance, and the upcoming October FDA date for MR-141 presents a massive TAM opportunity. A deeply undervalued turnaround play with strong institutional backing and a major pipeline catalyst. FDA rejection of MR-141 or failure to execute on the post-restructuring growth strategy.
HIGH
About VTRS Analyst Coverage
Buzzberg tracks VTRS (Viatris) across 2 sources. 2 bullish vs 0 bearish calls from 2 analysts. Sentiment: predominantly bullish (100%). 2 total trade ideas tracked. Past 7 days: 1 bullish. Latest voices: Alejandro Estebaranz, u/CoolioBeansTTV.